Latest News
Tanseisha Co., Ltd. H1 FY2027 Earnings Analysis: Absorbing the Post-Expo Rebound While Maintaining High Profit Margins; On Track to Meet ¥8.0 Billion Operating Profit Target
1. Earnings Overview and Highlights Tanseisha Co., Ltd. reported its consolidated f
INTLOOP（9556）FY26/7 通期決算ディープダイブ：先行投資フェーズを通過し急回復へ、高付加価値化とM&Aで描く次なる成長軌道
1. エグゼクティブサマリー：増収基調の維持と先行投資の結実 INTLOOP株式会社のFY26/7（2026年7月期）通期連結業績は、売上高40,399百万円（前期
Nareru Group Q3 FY2026 Earnings Deep Dive: Advancing the 'Change and Growth 2030' Mid-Term Plan through Improved Utilization and Rapid Expansion in Value-Added Segments
1. Q3 FY2026 Earnings Overview Nareru Group (Securities Code: 9163) reported revenue
トーホー 2027年1月期中間期決算：インバウンドとM&A効果で二桁増収・最高益基調、通期売上高予想を2,800億円へ上方修正
エグゼクティブ・サマリー 業務用食品卸で国内トップクラスのシェアを誇る株式会社トーホーは、2027年1月期中間期（第2四半期累計）において売上高1,364億55百万
ＮＡＴＴＹ ＳＷＡＮＫＹホールディングス 2027年1月期 半期決算：既存店の力強い回復と利益体質強化で営業黒字へ浮上、タイ初進出で新たな成長フェーズへ
株式会社ＮＡＴＴＹ ＳＷＡＮＫＹホールディングス（東証グロース：7674）は、2027年1月期半期決算を発表しました。主力ブランドである「肉汁餃子のダンダダン」の既存店売上が極
【ASIRO Q3 FY2026 Earnings Analysis】Breaking Free from High-Ticket Dependency with 21.6% Underlying Growth, Mid-to-Long Term Profit Expansion, and a 98% Total Payout Ratio
ASIRO, Inc.'s financial results for the third quarter of the fiscal year ending October
Global Style (7126) FY2026 Earnings Deep Dive: Record-High Profits, Accelerated Store Openings, and Future Growth Scenarios Driven by SNS Strategy
1. Earnings Overview and Key Performance Highlights Global Style Co., Ltd., operator
さくらさくプラス 2026年7月期 決算深掘りレポート：本業の堅調な拡大と新中計に見る「共働き世帯支援プラットフォーム」への進化
1. 2026年7月期 決算サマリーと業績動向の総括 株式会社さくらさくプラス（証券コード：7097）の2026年7月期通期決算は、売上高175億9,300万円（前
Macbee Planet Q1 FY2027 Earnings Analysis: A Comprehensive Review of New Management and Group Restructuring
Macbee Planet, Inc. (Securities Code: 7095) has announced its financial results for the
Nikko Co., Ltd. FY2027 Q1 Earnings Deep Dive: Strong Revenue Growth and Turnaround Driven by BP Business, with Profitability Recovery Expected in AP Business for H2
Nikko Co., Ltd. FY2027 Q1 Earnings Deep Dive Nikko Co., Ltd. (Securities Code: 6306),
Itokuro Q3 FY2026 Earnings Analysis: Exceeding Full-Year Profit Targets Through Optimized Investment Efficiency and Structural Transformation
Itokuro Inc.'s financial results for the third quarter of the fiscal year ending October
Japan Eyewear Holdings Q2 FY2027 Earnings Report: Record-Breaking Performance Driven by Inbound Demand and Higher Unit Prices
Japan Eyewear Holdings Co., Ltd. (Securities Code: 5889) reported record-high revenue
OHARA Inc. Q3 FY2026 Earnings Deep Dive: Surging Demand for Generative AI and Data Centers Drives Optical Business Restructuring; Full-Year Revenue Set to Reach Record Highs
Executive Summary For the first nine months of the fiscal year ending October 2026,
POPER 2026年10月期第3四半期決算：ストック収益シフトと顧客基盤拡大が進展、高収益Jカーブに向けた投資フェーズを解説
はじめに 教育DXプラットフォーム「Comiru（コミル）」を展開する株式会社POPERの2026年10月期第3四半期（3Q累計）決算は、売上高1,053百万円（
MediSync, Inc. H1 2026 Earnings Deep Dive: Completing Clinical Evaluations and Paving the Way for Upcoming Top-Line Data Releases
MediSync, Inc. H1 2026 Earnings Deep Dive 1. Executive Summary For the first half
ACCESS Q2 FY2027 Earnings Analysis: Double-Digit Revenue Growth and Significant Loss Reduction Driven by Network Business; Full-Year Profitability Plan and Internal Control Review Progress Detailed
ACCESS Q2 FY2027 Earnings Analysis: Double-Digit Revenue Growth and Significant Loss R
FUNDINNO Q3 FY2026 Earnings Deep Dive: Strategic Deal Selection Amid Market Shifts and Diversification of Investor Base and Funding Methods
Introduction FUNDINNO Inc. (Ticker: 462A), a leader in equity crowdfunding and
[BRANU Q3 FY2026 Earnings Report] Strong Growth with 39.8% Revenue and 60.0% Operating Profit Increases; Full-Year Guidance Revised Upward as AI Strategy 'BRANU AXIS' Launches
1. Q3 FY2026 Earnings Overview and Executive Summary BRANU Inc. (460A), a provid
StemRIM (4599) FY2026 Earnings In-Depth Analysis: Achieving Primary Endpoints in EB Phase 2 and Ischemic Stroke Phase 2b Results; A Comprehensive Overview of Financials and Development Toward 2028
Executive Summary For StemRIM Inc., a biopharmaceutical venture originating from Osa
HUMAN MADE FY2027 Q2 Earnings Deep Dive: A Global Growth Story Driven by Upward Revisions and Major Flagship Expansion
1. Earnings Overview: Record-Breaking Performance Leads to Upward Revision of Full-Ye